Treatment Adjustment and Medication Adherence for Complex Patients With Diabetes, Heart Disease, and Depression: A Randomized Controlled Trial

PURPOSE Medication nonadherence, inconsistent patient self-monitoring, and inadequate treatment adjustment exacerbate poor disease control. In a collaborative, team-based, care management program for complex patients (TEAMcare), we assessed patient and physician behaviors (medication adherence, self-monitoring, and treatment adjustment) in achieving better outcomes for diabetes, coronary heart disease, and depression. METHODS A randomized controlled trial was conducted (2007–2009) in 14 primary care clinics among 214 patients with poorly controlled diabetes (glycated hemoglobin [HbA1c] ≥8.5%) or coronary heart disease (blood pressure >140/90 mm Hg or low-density lipoprotein cholesterol >130 mg/dL) with coexisting depression (Patient Health Questionnaire-9 score ≥10). In the TEAMcare program, a nurse care manager collaborated closely with primary care physicians, patients, and consultants to deliver a treat-to-target approach across multiple conditions. Measures included medication initiation, adjustment, adherence, and disease self-monitoring. RESULTS Pharmacotherapy initiation and adjustment rates were sixfold higher for antidepressants (relative rate [RR] = 6.20; P <.001), threefold higher for insulin (RR = 2.97; P <.001), and nearly twofold higher for antihypertensive medications (RR = 1.86, P <.001) among TEAMcare relative to usual care patients. Medication adherence did not differ between the 2 groups in any of the 5 therapeutic classes examined at 12 months. TEAMcare patients monitored blood pressure (RR = 3.20; P <.001) and glucose more frequently (RR = 1.28; P = .006). CONCLUSIONS Frequent and timely treatment adjustment by primary care physicians, along with increased patient self-monitoring, improved control of diabetes, depression, and heart disease, with no change in medication adherence rates. High baseline adherence rates may have exerted a ceiling effect on potential improvements in medication adherence.

[1]  W. Katon,et al.  Functional outcomes of multi-condition collaborative care and successful ageing: results of randomised trial , 2011, BMJ : British Medical Journal.

[2]  Christopher G Parkin,et al.  A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study. , 2011, Diabetes technology & therapeutics.

[3]  Kurt C Stange,et al.  Transforming physician practices to patient-centered medical homes: lessons from the national demonstration project. , 2011, Health affairs.

[4]  R. Epstein,et al.  The Values and Value of Patient-Centered Care , 2011, The Annals of Family Medicine.

[5]  Do Peterson,et al.  Collaborative care for patients with depression and chronic illnesses. , 2010, The New England journal of medicine.

[6]  T. Fahey,et al.  Self-monitoring and other non-pharmacological interventions to improve the management of hypertension in primary care: a systematic review. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.

[7]  Richard J McManus,et al.  Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial , 2010, The Lancet.

[8]  Heather M. Tavel,et al.  Blood Pressure Trajectories and Associations With Treatment Intensification, Medication Adherence, and Outcomes Among Newly Diagnosed Coronary Artery Disease Patients , 2010, Circulation. Cardiovascular quality and outcomes.

[9]  W. Katon,et al.  Integrating depression and chronic disease care among patients with diabetes and/or coronary heart disease: the design of the TEAMcare study. , 2010, Contemporary clinical trials.

[10]  R. Baron,et al.  What's keeping us so busy in primary care? A snapshot from one practice. , 2010, The New England journal of medicine.

[11]  A. Parekh,et al.  The challenge of multiple comorbidity for the US health care system. , 2010, JAMA.

[12]  T. Bodenheimer,et al.  Care management of patients with complex health care needs. , 2009, The Synthesis project. Research synthesis report.

[13]  R. Stolk,et al.  Refill adherence and polypharmacy among patients with type 2 diabetes in general practice , 2009, Pharmacoepidemiology and drug safety.

[14]  W. Katon,et al.  Diabetes and Poor Disease Control: Is Comorbid Depression Associated With Poor Medication Adherence or Lack of Treatment Intensification? , 2009, Psychosomatic medicine.

[15]  B. O'Donnell,et al.  Prevalence of multiple chronic conditions in the United States' Medicare population , 2009, Health and quality of life outcomes.

[16]  C. Dowrick,et al.  Management of depression in UK general practice in relation to scores on depression severity questionnaires: analysis of medical record data , 2009, BMJ : British Medical Journal.

[17]  Randall S. Brown,et al.  Effects of care coordination on hospitalization, quality of care, and health care expenditures among Medicare beneficiaries: 15 randomized trials. , 2009, JAMA.

[18]  C. Lyketsos,et al.  Examining a bidirectional association between depressive symptoms and diabetes. , 2008, JAMA.

[19]  Brian J Zikmund-Fisher,et al.  The Role of Clinical Uncertainty in Treatment Decisions for Diabetic Patients with Uncontrolled Blood Pressure , 2008, Annals of Internal Medicine.

[20]  C. Hollenbeak,et al.  Effect of Unrelated Comorbid Conditions on Hypertension Management , 2008, Annals of Internal Medicine.

[21]  A. Karter,et al.  Why Don’t Diabetes Patients Achieve Recommended Risk Factor Targets? Poor Adherence versus Lack of Treatment Intensification , 2008, Journal of General Internal Medicine.

[22]  William D. Marder,et al.  Multiple Chronic Conditions: Prevalence, Health Consequences, and Implications for Quality, Care Management, and Costs , 2007, Journal of General Internal Medicine.

[23]  K. Stange.  Is ‘Clinical Inertia’ Blaming Without Understanding? Are Competing Demands Excuses? , 2007, The Annals of Family Medicine.

[24]  D. Ståhl,et al.  A Cohort Study of People With Diabetes and Their First Foot Ulcer , 2007, Diabetes Care.

[25]  Jacqueline A Pugh,et al.  Competing Demands or Clinical Inertia: The Case of Elevated Glycosylated Hemoglobin , 2007, The Annals of Family Medicine.

[26]  K. Chan,et al.  Methods for evaluation of medication adherence and persistence using automated databases , 2006, Pharmacoepidemiology and drug safety.

[27]  S. Martin,et al.  Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study , 2006, Diabetologia.

[28]  Evette Ludman,et al.  The association of comorbid depression with mortality in patients with type 2 diabetes. , 2005, Diabetes care.

[29]  W. Katon,et al.  Diabetes complications and depression as predictors of health service costs. , 2005, General hospital psychiatry.

[30]  J. Unützer,et al.  Improving Depression Care for Older, Minority Patients in Primary Care , 2005, Medical care.

[31]  W. Katon,et al.  Potentially Modifiable Factors Associated With Disability Among People With Diabetes , 2005, Psychosomatic medicine.

[32]  Wayne Katon,et al.  Depression and diabetes symptom burden. , 2004, General hospital psychiatry.

[33]  Wayne Katon,et al.  Relationship of depression and diabetes self-care, medication adherence, and preventive care. , 2004, Diabetes care.

[34]  J. Cramer.  A systematic review of adherence with medications for diabetes. , 2004, Diabetes care.

[35]  S. Saydah,et al.  Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. , 2004, JAMA.

[36]  J. Rosenstock,et al.  The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. , 2003, Diabetes care.

[37]  Laurence L. George,et al.  The Statistical Analysis of Failure Time Data , 2003, Technometrics.

[38]  Irl B Hirsch,et al.  The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. , 2003, General hospital psychiatry.

[39]  Christopher B Forrest,et al.  Comorbidity: Implications for the Importance of Primary Care in ‘Case’ Management , 2003, The Annals of Family Medicine.

[40]  Mark T Hegel,et al.  Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. , 2002, JAMA.

[41]  M. Robin DiMatteo,et al.  Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis , 2002, Medical care.

[42]  Jennifer Y. Liu,et al.  Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. , 2001, The American journal of medicine.

[43]  R. Glasgow,et al.  The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. , 2000, Diabetes care.

[44]  J. Schaefer,et al.  Collaborative Management of Chronic Illness , 1997, Annals of Internal Medicine.

[45]  Brian T. Austin,et al.  Organizing care for patients with chronic illness. , 1996, The Milbank quarterly.

[46]  W. Katon,et al.  Collaborative management to achieve treatment guidelines. Impact on depression in primary care. , 1995, JAMA.

[47]  T D Koepsell,et al.  A General Method of Compliance Assessment Using Centralized Pharmacy Records: Description and Validation , 1988, Medical care.

[48]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[49]  伸二 鍵本.  おさえておきたい 糖尿病の海外文献 ●文献●Depression and advanced complications of diabetes: a prospective cohort study. うつと糖尿病進行合併症：前向きコホート研究 , 2010 .

[50]  Brian T. Austin,et al.  Evidence on the Chronic Care Model in the new millennium. , 2009, Health affairs.

[51]  P. Bower,et al.  Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. , 2006, Archives of internal medicine.

[52]  J. Wofford.  Clinical inertia. , 2002, Annals of internal medicine.

[53]  R. Spitzer,et al.  The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.

[54]  L. Covi,et al.  The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions. , 1974, Modern problems of pharmacopsychiatry.